Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
25.04
0.07 (0.28%)
At close: Aug 15, 2025, 3:59 PM
25.11
0.30%
After-hours: Aug 15, 2025, 04:34 PM EDT

Janux Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-105.64M -77.74M -68.99M -60.54M -44.05M -55.59M -58.29M -62.6M -67.73M -67.11M -63.06M -60.41M -54.48M -43.8M -32.67M -20.91M -11.4M -7.66M
Depreciation & Amortization
2.08M 2.05M 2.06M 2.08M 2.07M 2.03M 1.96M 1.83M 1.58M 1.21M 841K 502K 280K 185K 113K 58K 32K 20K
Stock-Based Compensation
43.3M 38.1M 33.02M 31.25M 20.41M 20.16M 20M 19.73M 19.77M 18.72M 17.2M 15.94M 13.91M 10.74M 6.91M 4.01M 1.47M 193K
Other Working Capital
13.51M 11.19M 6.6M 7.08M -7.88M -9.71M -6.08M -4.54M -897K 6.11M 4.57M 4.92M 3.8M -2.65M -1.27M 6.44M 7.32M 8.36M
Other Non-Cash Items
-14.22M -11.99M -9.55M -8.69M -8.93M -7.8M -7.69M -6.92M -5.58M -3.84M -2.18M 12.54M 13.23M 13.3M 5.49M -140K -16K 1.37M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -13.49M -13.49M -13.49M -13.49M n/a n/a n/a
Change in Working Capital
14.69M 3.59M -345K -1.1M -15.98M -10.3M -6.55M -4.62M -2.34M 5.7M 4.28M 3.42M 6.62M -1M 8.84M 8.83M 6.58M 8.16M
Operating Cash Flow
-59.79M -46M -43.81M -36.99M -46.47M -51.5M -50.58M -52.59M -54.29M -45.31M -42.92M -41.49M -33.93M -34.06M -16.98M -8.12M -3.35M 2.07M
Capital Expenditures
-911K -533K -359K -832K -1.28M -1.76M -1.85M -3.39M -5.44M -5.76M -6.45M -5.56M -3.12M -2.3M -1.48M -309K -232K -153K
Cash Acquisitions
n/a n/a n/a -11.64M 49.34M 30.89M 39.34M 50.98M -32.28M -23.77M -32.22M -152.59M -130.31M -120.37M -120.37M n/a n/a n/a
Purchase of Investments
-520.47M -663.33M -470.58M -479.66M -583.17M -424.18M -317.34M -370.28M -328.77M -321.03M -294.39M -311.84M -444.98M -518.69M -473.63M -370.13M -142.52M n/a
Sales Maturities Of Investments
229.16M 179.19M 212.91M 199.66M 229.5M 279.75M 278M 319.75M 361.5M 345.25M 359.1M 384.6M 290M 211.25M 134.15M 22.14M n/a n/a
Other Investing Acitivies
n/a n/a n/a 11.64M -49.34M -30.89M -39.34M -50.98M 32.28M 23.77M 64.26M 184.63M 184.49M 32.04M n/a -120.37M -142.52M n/a
Investing Cash Flow
-292.23M -484.68M -258.02M -280.82M -354.95M -146.19M -41.19M -53.92M 27.29M 18.46M 58.27M 67.2M -158.11M -309.74M -340.96M -348.29M -142.75M -153K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.66M 1.66M 1.74M 2.26M 2.19M 2.38M 2.3M 2.08M 500K 473K 473K 205.28M 206.82M 206.72M 206.69M 6.08M
Financial Cash Flow
389.81M 391.62M 713.24M 327.42M 382.38M 380.14M 59.55M 58.91M 2.3M 2.08M 500K 473K -370K 328.98M 386.52M 390.91M 391.72M 67.57M
Net Cash Flow
37.78M -139.06M 411.4M 9.6M -19.04M 182.45M -32.22M -47.6M -24.7M -24.77M 15.84M 26.18M -192.41M -14.82M 28.59M 34.5M 245.62M 69.48M
Free Cash Flow
-60.7M -46.53M -44.17M -37.82M -47.74M -53.26M -52.42M -55.98M -59.73M -51.07M -49.37M -47.05M -37.05M -36.36M -18.46M -8.43M -3.58M 1.92M